AbCellera Biologics Inc. ABCL Contract with Customer, Liability
Contract with Customer, Liability at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s contract with customer, liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s contract with customer, liability?
- AbCellera Biologics Inc. (ABCL) reported contract with customer, liability of $8.99M in Q1 2026.
- How has AbCellera Biologics Inc.'s contract with customer, liability changed year-over-year?
- AbCellera Biologics Inc.'s contract with customer, liability decreased by 72.4% year-over-year, from $32.54M to $8.99M.
- What is the long-term trend for AbCellera Biologics Inc.'s contract with customer, liability?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s contract with customer, liability has grown at a -16.5% compound annual growth rate (CAGR), from $34.95M to $17.03M.